Feedback
Settings

Settings

1. WO2008096126 - COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST

PermaLink
Publication Number WO/2008/096126
Publication Date 14.08.2008
International Application No. PCT/GB2008/000404
International Filing Date 06.02.2008
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42
Oxazoles
421
1,3-Oxazoles, e.g. pemoline, trimethadione
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425
Thiazoles
428
condensed with carbocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
16
Amides, e.g. hydroxamic acids
165
having aromatic rings, e.g. colchicine, atenolol, progabide
167
having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11
Drugs for disorders of the respiratory system
06
Antiasthmatics
A61K 31/421 (2006.01)
A61K 31/428 (2006.01)
A61K 31/167 (2006.01)
A61P 11/06 (2006.01)
CPC
A61K 31/167
A61K 31/421
A61K 31/428
Applicants
  • ARGENTA DISCOVERY LTD [GB/GB]; 8/9 Spire Green Centre Flex Meadow Harlow Essex, CM19 5TR, GB (AllExceptUS)
  • ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje, SE (AllExceptUS)
  • FINCH, Harry [GB/GB]; GB (UsOnly)
  • WILEY, Katherine [GB/GB]; GB (UsOnly)
  • DIXON, John [GB/GB]; GB (UsOnly)
Inventors
  • FINCH, Harry; GB
  • WILEY, Katherine; GB
  • DIXON, John; GB
Agents
  • STANSFIELD, Kevin ; AstraZeneca AB AstraZeneca Intellectual Property S-151 85 Södertälje, SE
Priority Data
0702385.607.02.2007GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST
(FR) COMBINAISON D'UN ANTAGONISTE DU RÉCEPTEUR MUSCARINIQUE ET D'UN AGONISTE DE L'ADRÉNORÉCEPTEUR β2
Abstract
(EN)
The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a selected muscarinic receptor antagonist selected, and a second active ingredient which is a β2-adrenoceptor agonist, of use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma.
(FR)
L'invention concerne un produit pharmaceutique, une trousse ou une composition comprenant une premier ingrédient actif qui est un antagoniste du récepteur muscarinique choisi et un second ingrédient actif qui est un agoniste de l'adrénocepteur β2, destinés au traitement de maladies respiratoires telles que la maladie pulmonaire obstructive chronique et l'asthme.
Also published as
AU2008212649
CA2675718
CN101678005
EP2124941
IN4986/DELNP/2009
JP2010518059
KR1020090114389
MXMX/a/2009/008363
RU0002460527
RU2009133261
RU2009133261
US20110046191
Latest bibliographic data on file with the International Bureau
# -